ANDA 209974, held by Pai Holdings Pharm. Clobetasol Propionate.
As of Nov 16, 2026, ANDA 209974 (Clobetasol Propionate), held by Pai Holdings Pharm, was first approved by FDA on Apr 17, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 17, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clobetasol Propionate0.05% ยท cream;topical | Clobetasol Propionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters